Let's get small (and smaller): Combining zebrafish and nanomedicine to advance neuroregenerative therapeutics

David T. White, Meera T. Saxena, Jeffrey Mumm

Research output: Contribution to journalArticle

Abstract

Several key attributes of zebrafish make them an ideal model system for the discovery and development of regeneration promoting therapeutics; most notably their robust capacity for self-repair which extends to the central nervous system. Further, by enabling large-scale drug discovery directly in living vertebrate disease models, zebrafish circumvent critical bottlenecks which have driven drug development costs up. This review summarizes currently available zebrafish phenotypic screening platforms, HTS-ready neurodegenerative disease modeling strategies, zebrafish small molecule screens which have succeeded in identifying regeneration promoting compounds and explores how intravital imaging in zebrafish can facilitate comprehensive analysis of nanocarrier biodistribution and pharmacokinetics. Finally, we discuss the benefits and challenges attending the combination of zebrafish and nanoparticle-based drug optimization, highlighting inspiring proof-of-concept studies and looking toward implementation across the drug development community.

Original languageEnglish (US)
JournalAdvanced Drug Delivery Reviews
DOIs
StatePublished - Jan 1 2019

Keywords

  • Drug optimization
  • Nanocarrier
  • Neurodegeneration
  • Neuroregeneration

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Let's get small (and smaller): Combining zebrafish and nanomedicine to advance neuroregenerative therapeutics'. Together they form a unique fingerprint.

  • Cite this